![ASCO 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/5/eadfa937-de35-4504-be38-58654669525f.png.200x0_q85.png)
ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on Phase I/II Trial of Encorafenib, Cetuximab, & Nivolumab in Patients With MSS BRAFV600E mCRC
By
ASCO 2022 Conference Coverage
FEATURING
Van Morris
By
ASCO 2022 Conference Coverage
FEATURING
Van Morris
334 views
June 28, 2022
Login to view comments.
Click here to Login
GI